During the past three decades or so, the incidence of fungal infections has increased dramatically. Deep-seated mycoses are creating serious problems for clinicians working with certain populations of patients, such as those with cancer, those who are immunocompromised, and those who are physiologically compromised (1,2).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Georgiev, V. St. (1997) Infectious Diseases in Immunocompromised Hosts, CRC Press, Boca Raton, FL, pp. 739–1189.
Georgiev, V. St. (2001) Opportunistic Infections: Treatment and Prophylaxis, Humana Press, Totowa, NJ.
Georgiev, V. St. (1992) Treatment and developmental therapeutics in aspergillosis. 1. Amphotericin B and derivatives, Respiration, 59, 291–302.
Georgiev, V. St. (1992) Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs, Respiration, 59 303–313.
Georgiev, V. St. (1993) Opportunistic/nosocomial infections. Treatment and developmental therapeutics. I. Cryptococcosis, Med. Res. Rev., 13, 493–506.
Georgiev, V. St. (1993) Opportunistic/nosocomial infections. Treatment and developmental therapeutics. II. Cryptococcosis, Med. Res. Rev., 13, 507–527.
Georgiev, V. St. (1993) Opportunistic infections: treatment and developmental therapeutics of cryptosporidiosis and isosporiasis, Drug Dev. Res. 28, 445–459.
Georgiev, V. St. (1995) Treatment and developmental therapeutics of blastomycosis, Int. J. Antimicrob. Agents, 6, 1–12.
Valdivia, L., Nix, D., Wright, M., Lindberg, E., Fagan, T., Lieberman, D., Stoffer, T. P., Ampel, N. M., and Galgiani, J. N. (2006) Coccidioidomycosis as a common cause of community-acquired pneumonia, Emerg. Infect. Dis., 12(6), 958–962.
Ritterhous, P. C., Kechchian, T. B., Allegood, J. C., Merrill, A. H., Jr., Hennig, M., Luberto, C., and Del Poeta, M. (2006) Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans, J. Clin. Invest., 116(6), 1651–1659.
Nemecek, J. C., Wuthrich, M., and Klein, B. C. (2006) Global control of dimorphism and virulence in fungi, Science, 312(5773), 583–588.
Allen, H. L. and Deepe, G. S., Jr. (2005) Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum, J. Clin. Invest., 115(10), 2875–2885.
Selmecki, A., Forche, A., and Berman, J. (2006) Aneuploidy and isochromosome formation in drug-resistant Candida albicans, Science, 313(5785), 367–370.
Shubitz, L. F., Yu, J.-J., Hung, C.-Y., Kirkland, T. N., Peng, T., Perrill, R., Simons, J., Xue, J., Herr, R. A., Cole, G. T., and Galgiani, J. N. (2006) Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein, Vaccine, 24(31–32), 5904–5911.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Georgiev, V.S. (2009). Fungal Diseases. In: Georgiev, V.S. (eds) National Institute of Allergy and Infectious Diseases, NIH. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-297-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-60327-297-1_5
Publisher Name: Humana Press
Print ISBN: 978-1-60327-296-4
Online ISBN: 978-1-60327-297-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)